Breakdown | TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 17.36M | 16.36M | 4.11M | 3.62M | 1.08M | 2.07M |
Gross Profit | 10.77M | 10.26M | 2.38M | 3.34M | 1.05M | 1.88M |
EBITDA | -7.92M | -8.96M | -14.24M | -13.04M | -11.45M | -20.62M |
Net Income | -10.33M | -11.06M | -16.34M | -39.72M | -16.56M | -25.13M |
Balance Sheet | ||||||
Total Assets | 21.29M | 24.94M | 19.00M | 18.06M | 49.40M | 66.01M |
Cash, Cash Equivalents and Short-Term Investments | 5.43M | 8.63M | 8.33M | 6.28M | 9.65M | 26.43M |
Total Debt | 1.12M | 380.93K | 356.84K | 677.28K | 985.92K | 1.01M |
Total Liabilities | 11.41M | 10.97M | 4.26M | 3.51M | 2.56M | 3.79M |
Stockholders Equity | 9.88M | 13.97M | 14.74M | 14.55M | 46.84M | 62.22M |
Cash Flow | ||||||
Free Cash Flow | -7.16M | -8.57M | -13.57M | -9.37M | -12.26M | -18.70M |
Operating Cash Flow | -6.31M | -8.14M | -13.54M | -9.27M | -11.69M | -17.57M |
Investing Cash Flow | -1.27M | -429.75K | 364.46K | -95.76K | -544.96K | -10.96M |
Financing Cash Flow | 8.84M | 8.87M | 15.22M | 5.99M | -514.96K | 301.40K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | C$97.79M | 9.84 | 135.14% | ― | 92.08% | 100.09% | |
64 Neutral | C$55.97M | 37.00 | 5.09% | ― | -0.92% | -23.37% | |
63 Neutral | $32.90B | 6.03 | -11.70% | 1.95% | 5.55% | -19.87% | |
57 Neutral | C$37.72M | ― | -244.21% | ― | 51.52% | 50.73% | |
55 Neutral | C$131.49M | 35.86 | 59.35% | ― | 253.50% | ― | |
49 Neutral | C$61.56M | ― | -90.88% | ― | 349.56% | -928.83% | |
47 Neutral | C$72.08M | ― | -99.03% | ― | 29.22% | 18.54% |
Xtract One Technologies has been chosen by San Mateo Medical Center in California to deploy its SmartGateway system, enhancing security with AI-powered weapon detection. This initiative aligns with California’s new mandate for hospital weapons detection, aiming to improve safety and reduce disruptions, thereby positioning San Mateo Medical Center as a proactive leader in healthcare security.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$1.50 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies has successfully closed an $8 million bought deal public offering, with full exercise of the over-allotment option. The proceeds from this offering will be used for working capital and general corporate purposes, potentially strengthening the company’s operational capabilities and market position in the security solutions industry.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$0.80 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies Inc. has announced a $7 million ‘bought deal’ public offering, with Ventum Capital Markets agreeing to purchase 18 million units at $0.39 per unit. The proceeds will be used for working capital and general corporate purposes, and the offering is expected to close around June 18, 2025, subject to regulatory approvals. This move is poised to bolster Xtract One’s financial position, allowing further investment in their AI-driven security solutions, potentially enhancing their market leadership in threat detection.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$0.80 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies reported its fiscal third quarter results, highlighting a decrease in revenue to $3.5 million compared to the previous year, attributed to delayed deployments. Despite this, the company maintains a strong contractual backlog and is optimistic about future growth, especially with the upcoming shipment of its newly certified Xtract One Gateway platform. The company has secured significant orders and partnerships, including with the Colorado Rockies, positioning it well for the remainder of the fiscal year.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$1.50 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies announced that its new security platform, Xtract One Gateway, is set to begin shipping in July, with orders valued at approximately $6.7 million. The system, which has been certified in the U.S. and Canada, is designed to streamline security checks by unobtrusively scanning individuals and their belongings for potential threats while distinguishing harmless items. The strong market response and rising demand indicate a positive impact on the company’s operations and industry positioning, as it continues to engage with customers across various sectors.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$0.80 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies announced the release of its fiscal 2025 third quarter results, scheduled for June 5, 2025. The company will host a webcast and conference call on June 6, 2025, led by CEO Peter Evans and CFO Karen Hersh, to discuss the financial results and provide a business outlook. This announcement highlights Xtract One’s commitment to transparency and its strategic focus on leveraging AI for security solutions, potentially reinforcing its market position and stakeholder confidence.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$0.80 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies has partnered with the Colorado Rockies to implement its SmartGateway system at Coors Field, aiming to enhance fan safety and streamline entry processes. This deployment replaces traditional metal detectors, allowing faster and more efficient security checks, and aligns with the Rockies’ mission to improve game-day experiences. The SmartGateway system uses AI-powered sensors to unobtrusively scan patrons, reducing wait times and providing proactive security insights, thus positioning Xtract One as a leader in modern stadium security solutions.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$0.80 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies has partnered with Major League Baseball’s Colorado Rockies to deploy its SmartGateway system at Coors Field. This collaboration aims to enhance stadium security by introducing a frictionless, AI-powered screening process that significantly reduces wait times and improves the overall game-day experience for fans. The deployment of SmartGateway aligns with the Rockies’ commitment to integrity and quality, offering a proactive security solution that unobtrusively scans patrons and detects threats without compromising privacy.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$0.80 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.
Xtract One Technologies has entered a Master Supply Agreement with a global media and entertainment organization to deploy its SmartGateway security screening solution. This agreement marks a significant step for Xtract One, as its AI-powered technology will be used to enhance security across the entertainment company’s venues worldwide, starting with a location in Asia. The SmartGateway’s ability to provide fast, reliable, and accurate patron screening sets a new standard in the industry, offering a proactive approach to security that maintains guest privacy and reduces wait times.
The most recent analyst rating on (TSE:XTRA) stock is a Buy with a C$0.80 price target. To see the full list of analyst forecasts on Xtract One stock, see the TSE:XTRA Stock Forecast page.